What is Yupelri 175 mg?
Yupelri is a medication used to treat a chronic lung disease called bronchiectasis. It is administered as a nebulized solution, meaning it is turned into a fine mist for inhalation. The standard dose is 175 mg. [1]
How does Yupelri work for bronchiectasis?
Yupelri works by helping to clear mucus from the lungs, which is a common problem for individuals with bronchiectasis. By reducing mucus accumulation, it can help improve lung function and reduce the frequency of exacerbations (flare-ups) of the disease. [1]
When does Yupelri's patent expire?
The patent protection for Yupelri is a key factor in its market availability and potential competition. Information on specific patent expiry dates can be found through resources that track drug patents. According to DrugPatentWatch.com, details regarding Yupelri's patent status are available, which can indicate when generic versions might become available. [2]
What are the potential alternatives to Yupelri?
For individuals with bronchiectasis, treatment approaches can vary. Other inhaled therapies may be used to manage mucus clearance, depending on the patient's specific condition and doctor's recommendations. These could include other types of mucolytics or bronchodilators, or physiotherapy techniques aimed at airway clearance. [1]
What are the risks associated with Yupelri?
Like all medications, Yupelri carries potential risks and side effects. Common side effects reported include cough, oral candidiasis (thrush), and diarrhea. More serious adverse events can occur, and patients should discuss any concerns with their healthcare provider. [1]
What clinical data supports Yupelri's use?
Clinical trials have been conducted to evaluate the efficacy and safety of Yupelri. These studies have focused on its ability to reduce exacerbations and improve lung function in patients with bronchiectasis. [1]
Sources:
1. https://www.yuplri.com/
2. https://drugpatentwatch.com/